Purchase Order HHSN311201700342P
Award Date 9/18/17
Potential Completion Date 10/18/17
Potential Value $5.2K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Institute on Aging issued a purchase order to Stemcell Technologies Inc. on September 7, 2017, for $14,773.50, with final delivery due October 7, 2017. Work is performed in Baltimore, Maryland. The order procures biological research materials and cell culture supplies from Stemcell Technologies' commercial product portfolio, including cell isolation kits, automated cell separation instruments, and related consumables supporting federal health research operations.</p>
- The National Institute on Aging awarded a purchase order to Stemcell Technologies Inc. on July 26, 2017 for $14,749.28, with an ultimate completion date of September 20, 2017. The procurement used no set-aside category and carried firm fixed price terms. Place of performance is Baltimore, Maryland. The order procures specialized biological research materials and instruments from Stemcell Technologies' commercial product line, which includes cell isolation kits, automated cell separators, and...
- <p>The National Institute on Aging awarded a purchase order to Stemcell Technologies Inc. for $6,626.25 on November 27, 2017, with completion targeted for November 28, 2018. Performance takes place in Baltimore, Maryland. The order procures specialized biological research materials or cell culture products from Stemcell Technologies' commercial product portfolio, supplied on a firm fixed-price basis under full-and-open competition.</p>
- The National Institute on Aging issued a purchase order to Stemcell Technologies Inc. on August 21, 2017, for $11,186.00, with completion by September 20, 2017. No set-aside was used. Performance occurs in Burien, Washington. The order procures specialized biological research materials and cell isolation or separation equipment from Stemcell's commercial product lines, typically including EasySep kits, RoboSep-S automated cell separators, or related reagents and consumables supporting aging...
- <p>The National Institute on Aging awarded a purchase order to Stemcell Technologies Inc. for $1,027.50 on June 20, 2014, with completion due July 20, 2014. Place of performance is Burien, Washington. No set-aside was used. The order covers specialized biological research materials or reagents from Stemcell's commercial product line, which includes EasySep cell isolation kits, RoboSep-S automated cell separators, and related consumables supporting federal health research operations.</p>
- <p>The National Institute on Aging issued a purchase order to Stemcell Technologies Inc. on March 12, 2018, valued at $8,835.00 for maintenance, repair, and rebuild of laboratory instruments and equipment. Performance is located in Baltimore, Maryland, with an ultimate completion date of March 31, 2019. The order is firm fixed price with no set-aside designation.</p>
- Stemcell Technologies Inc. was awarded a firm fixed price purchase order valued at twenty-four thousand eight hundred eighty dollars and sixty-two cents ($24,880.62) by the Department of Health and Human Services' National Institutes of Health National Institute on Aging on September 17, 2019. The award has no set-aside designation. Stemcell Technologies Inc. is a subsidiary of Stemcell Technologies, a Canadian company that develops cell culture media, separation systems, and other life sciences...
- This is a federal purchase order contract awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract, valued at $23,828.70, is for the delivery of REAGENT MATERIALS - EASYSEP HUMAN IMMUNE CELL ISOLATION KITS by the prime contractor, Stemcell Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is a firm fixed-price purchase order with an ultimate...
- The NIH Clinical Center awarded a purchase order to Stemcell Technologies Inc. for $10,313.00 on September 6, 2017, with an ultimate completion date of September 5, 2018. No set-aside was used. Performance occurs at Bethesda, Maryland. The order is firm fixed-price and procures biological research products and laboratory supplies—including cell isolation kits, cell culture media, reagents, and specialized scientific equipment—to support biomedical research initiatives at the NIH Clinical...
- The National Institute on Drug Abuse awarded a purchase order to Stemcell Technologies Inc. for $162,655.20 on August 5, 2024, for maintenance and repair services for RoboSep-S automated immunomagnetic cell separation equipment. The order carries no set-aside designation. Work is performed at Kent, Washington. The purchase order covers preventive maintenance, software upgrades, and on-site support for government-owned equipment through August 4, 2029. The originating pre-solicitation notice...